Insights & Publications
Publications
Utility of Commercially Available Quantitative hCG Immunoassays as Tumor Markers in Trophoblastic and Non-Trophoblastic Disease
Abstract Background: The use of quantitative human chorionic gonadotropin (hCG) as a tumor marker is widely accepted despite lack of FDA-approval for oncology. Differences in iso- and glycoform recognition among hCG immunoassays is well established, exhibiting wide inter-method variability. Here, we assess the utility of 5 quantitative hCG immunoassays for use as tumor markers in…
Why Labs Should Partner with Payers and Providers
Through these collaborations, clinical laboratories can use their expertise and data to improve outcomes, save money, and increase their influence within the healthcare system.
Laboratory Developed Tests: Regulation, Assay Development, and Impact on Patient Care
JMSACL_VALID_Intro Paragraph_FINAL Journal of Mass Spectrometry and Advances in the Clinical Lab | Laboratory Developed Tests: Regulation, Assay Development, and Impact on Patient Care | ScienceDirect.com by Elsevier
Commentary on Unexpected Fentanyl Detection during a Liver Transplant Evaluation
This case highlights the potential consequences that false-positive (FP) urine drug screen (UDS) results can have on patient care and reinforces the need to confirm preliminary screen results with a direct method, such as liquid chromatography–tandem mass spectrometry (LC-MS/MS). Rather than act on the unexpected results, the transplant team appropriately consulted the laboratory and confirmatory…